Stereotactic body radiotherapy (SBRT) is an established treatment for previously unirradiated spinal metastases, however...

First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...

New research presented at the 67th American Society of Hematology (ASH) Annual Meeting in December 2025...

In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...

The first curative lung cancer surgeries connected to the Lung Health Check pilot programme have taken...

Ciltacabtagene autoleucel (cilta-cel) has demonstrated unprecedented response rates and progression-free survival (PFS)...

The absence of circulating tumour cells (CTCs) defines a subtype of multiple myeloma (MM) with unique...

Dr Iseult Browne, Royal Marsden Hospital, London, UK, delivered a presentation titled ‘Integrating circulating tumour DNA...

For most patients, the moment a doctor utters the words “you have cancer” is not simply...

Speaking at Gathering Around Cancer 2025, Prof Seamus O’Reilly, Cork University Hospital, provided an update on...

In this issue, psilocybin therapy in the HSE, safe prescribing for adult patients with ADHD,and highlights...

Most mental health issues begin in the first 20 years of life, with many problems persisting...